newsfilter
← Latest News
ACCESS Newswire·

enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year

Continued progress toward submission of 5th and final module of FDA premarket approval application for VenoValve® in Q4GLP study for enVVe® transcatheter-based replacement venous valve underway; On track